Drug makers and wholesalers to dispute about credit collection allowances.

The pharmaceutical industry and wholesalers are under a hot dispute about the credit collection allowances. The drug industry widely admitted that the credit allowances should be eliminated in view of blocking any clue for the government's habitual price slash of NHI drugs.

The MOHW earlier officially interpreted that even the credit collection allowance be a good reason for the drug price r...